跳至主要内容
临床试验/NCT04790773
NCT04790773终止不适用

Alexa, What is Eliquis and Xarelto?

Cedars-Sinai Medical Center2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2021年5月21日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
36
试验地点
2
主要终点
% Change in pre- and post test scores

研究概览

简要总结

The purpose of this study is to evaluate the effectiveness of providing patient medication education about Eliquis and Xarelto through an Amazon Alexa based voice recording.

详细描述

Anticoagulants are considered high-risk medications due to the risk of major bleeding. The Federal Drug and Food Administration (FDA) MedWatch reporting system found that anticoagulants had the most adverse drug event (ADE) reports in 2011. Anticoagulants have also been reported as one of the leading drug classes contributing to emergency department visits3. Given the potential for serious adverse events, providing effective education to increase patient knowledge and awareness of those risks are essential. Incorporating technology into health care is becoming increasingly popular and has been shown to be effective for patient education. One reason is that technology can consistently provide complete patient education and is not subject to educator variability in providing this education.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Patients will be excluded if they have documented altered mental status, do not speak English, or are being prescribed rivaroxaban or apixaban on discharge only.
  • Nurses will be excluded if not providing direct patient care in select general medicine and orthopedic surgical units
  • Nurses declining participation

结局指标

主要结局

% Change in pre- and post test scores

时间窗: Within 72 hours of education

Effectiveness of Alexa based education by assessing understanding of Eliquis and Xarelto pre and post Alexa education

次要结局

  • 7-day post-education retention rate(1 week post discharge)
  • Patient satisfaction(72 hours)
  • Nursing satisfaction(72 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kaman Chung

Pharmacy Manager

Cedars-Sinai Medical Center

研究点 (2)

Loading locations...

相似试验